Learn from the MHRA about evolving CMC expectations, submission criteria, and initiatives for streamlining approval routes for mRNA platforms. Continuous processing: Optimizing efficiency & ...

In vitro-transcribed mRNAs have been proven efficient in various therapeutic applications. However, manufacturing them poses challenges due in part to complexity of the molecules as well as the ...

RNA-based therapeutics require scalable manufacturing strategies capable of producing high mRNA yields while efficiently using costly reagents. In vitro transcription (IVT) represents a critical step ...

Stay ahead in the booming mRNA market, projected to reach $63.28 billion by 2025, with the 3 rd mRNA Process Development & Manufacturing Summit 2025 - Europe’s premier industry-focused forum dedicated ...

The success of the mRNA-based vaccines against SARS-CoV-2 merely hint at the healthcare implications of mRNA technology. More mRNA-based vaccines are in the works, as are mRNA-based therapeutics for ...

Decoding of messenger RNA (mRNA) occurs during translation, the vital cellular process that builds proteins. Errors in this ...

Dublin, April 14, 2026 (GLOBE NEWSWIRE)-- The "Messenger Ribo Nucleic Acid (mRNA) Vaccine Contract Development and Manufacturing Organization (CDMO) Market Report 2026" has been added to ...

Newswise — Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional ...

The promise of mRNA technology lies in its potential to enable flexible and targeted therapies faster. mRNA therapies offer several key advantages, such as the ability to quickly adapt to emerging ...

A newly approved messenger RNA (mRNA) influenza vaccine could help improve protection against seasonal flu by allowing manufacturers to develop and produce vaccines more quickly as circulating virus ...